Please assess the completion status of the following clinical trial:

Trial Title: Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Provision of informed consent prior to any study specific procedures~* Men or women age ≥20 years old (Either gender needs to be 40% or higher of total number of treated subjects)diagnosed with type 2 DM ; ≥6.5% and ≤10% at 1 week before randomization~Exclusion Criteria:~* Type 1 diabetes mellitus~* FPG \>240 mg/dL before randomization~* Subjects who have history of unstable or rapidly progressing renal disease~* Subjects who have severe hepatic insufficiency and/or significant abnormal liver function~* Significant cardiovascular history

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Dapagliflozin 5 mg
- 2 (Type: EXPERIMENTAL): Dapagliflozin 10 mg
- 3 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).